Antonio Convit

Antonio Convit

Auto-generated profile, based on publicly available information

Antonio Convit

Department of Psychiatry, New York University School of Medicine, New York, New York, USA

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1998 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
SLSonia J. Lupien
Sonia J. Lupien
MLMony de Leon
Mony de Leon
SSSusan de Santi
Susan de Santi
ACAntonio Convit
Antonio Convit
CTChaim Tarshish
Chaim Tarshish
MMMichael J. Meaney
Michael J. Meaney

8 November 2007 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
IDIsabel Dziobek
Isabel Dziobek
KRKimberley Rogers
Kimberley Rogers
SFStefan Fleck
Stefan Fleck
MBMarkus Bahnemann
Markus Bahnemann
HHHauke R. Heekeren
Hauke R. Heekeren
ACAntonio Convit
Antonio Convit

6 June 2006 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
IDIsabel Dziobek
Isabel Dziobek
SFStefan Fleck
Stefan Fleck
EKElke Kalbe
Elke Kalbe
KRKimberley Rogers
Kimberley Rogers
JHJason Hassenstab
Jason Hassenstab
ACAntonio Convit
Antonio Convit

28 August 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MLM. J. de Leon
M. J. de Leon
ACA. Convit
A. Convit
OWOliver T. Wolf
Oliver T. Wolf
CTC. Y. Tarshish
C. Y. Tarshish
SDS. DeSanti
S. DeSanti
JFJ. Fowler
J. Fowler
Neuropathology studies show that patients with mild cognitive impairment (MCI) and Alzheimer's disease typically have lesions of the entorhinal cortex (EC), hippocampus (Hip), and temporal neocortex. Related observations with in vivo imaging have enabled the prediction of dementia from MCI. Although individuals with normal cognition may have focal EC lesions, this anatomy has not been studied as a predictor of cognitive decline and brain change. The objective of this MRI-guided 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET) study was to examine the hypothesis that among normal elderly subjects, EC METglu reductions predict decline and the involvement of the Hip and neocortex. In a 3-year longitudinal study of 48 healthy normal elderly, 12 individuals (mean age 72) demonstrated cognitive decline (11 to MCI and 1 to Alzheimer's disease). Nondeclining controls were matched on apolipoprotein E genotype, age, education, and gender. At baseline, metabolic reductions in the EC accurately predicted the conversion from normal to MCI. Among those who declined, the baseline EC predicted longitudinal memory and temporal neocortex metabolic reductions. At follow-up, those who declined showed memory impairment and hypometabolism in temporal lobe neocortex and Hip. Among those subjects who declined, apolipoprotein E E4 carriers showed marked longitudinal temporal neocortex reductions. In summary, these data suggest that an EC stage of brain involvement can be detected in normal elderly that predicts future cognitive and brain metabolism reductions. Progressive E4-related hypometabolism may underlie the known increased susceptibility for dementia. Further study is required to estimate individual risks and to determine the physiologic basis for METglu changes detected while cognition is normal.

1 July 2001 in Neurobiology of Aging
Verified
Journal Article
Closed access
SSSusan De Santi
Susan De Santi
MLMony J de Leon
Mony J de Leon
HRHenry Rusinek
Henry Rusinek
ACAntonio Convit
Antonio Convit
CTChaim Y Tarshish
Chaim Y Tarshish
JFJoanna Fowler
Joanna Fowler

14 February 2007 in Diabetologia
Verified
Journal Article
Closed access
PDF file
SGS. M. Gold
S. M. Gold
IDI. Dziobek
I. Dziobek
VSV. Sweat
V. Sweat
ATA. Tirsi
A. Tirsi
KRK. Rogers
K. Rogers
ACA. Convit
A. Convit